{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:33:53Z","timestamp":1788932033462,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Masseter hypertrophy is the main cause of an asymmetrical and squared lower facial contour in the Asian community. Botulinum toxin injection technique is crucial to treat this condition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To improve injection techniques for masseter hypertrophy by elucidating the distribution of the injections within the masseter.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Thirty masseter muscles were divided into 6 groups of 5 muscles each. Each group received one 0.2- or 0.3-mL injection at Point A, B, or C according to a three-point technique. Muscle dimensions and dye of the primary and secondary dye spreading were measured.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>The average muscle length, width, and thickness were 69.87, 33.50, and 11.23 mm, respectively. The average primary longitudinal and horizontal spreading was 36.56 and 15.60 mm, respectively. No statistically significant difference was found between 0.2- and 0.3-mL injections at each point.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>The three-point technique best fits in the safe zone and should be the standard injection technique for masseter hypertrophy. Injection at Points B and C may create secondary spreading that affect the risorius muscle and the parotid gland which are the cause of asymmetrical smiling and xerostomia, respectively. The dosage should be adjusted according to the muscle volume and not only the thickness.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000003171","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T02:09:49Z","timestamp":1629511789000},"page":"1354-1358","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["A Cadaveric Study of Dye Spreading: Determining the Ideal Injection Pattern for Masseter Hypertrophy"],"prefix":"10.1097","volume":"47","author":[{"given":"Peerada","family":"Sermswan","sequence":"first","affiliation":[{"name":"Faculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvaa","family":"Tansatit","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiraroch","family":"Meevassana","sequence":"additional","affiliation":[{"name":"Center of Excellence in Burn and Wound Care, Chulalongkorn University, Bangkok, Thailand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratchathorn","family":"Panchaprateep","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"R1-20250731","first-page":"361","article-title":"Enlargement of the temporal and masseter muscles on both sides","volume":"31","author":"Legg","year":"1880","journal-title":"Trans Pathol Soc London"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archotol.1961.00740020019002","article-title":"The nature of masseteric hypertrophy","volume":"73","author":"Guggenheim","year":"1961","journal-title":"Arch Otolaryngol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/dsu.12317","article-title":"Consensus recommendations on the aesthetic usage of botulinum toxin type A in Asians","volume":"39","author":"Ahn","year":"2013","journal-title":"Dermatol Surg"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ca.23337","article-title":"Ultrasonography of the internal architecture of the superficial part of the masseter muscle in vivo","volume":"32","author":"Lee","year":"2019","journal-title":"Clin Anat"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/toxins9010014","article-title":"The anatomical basis of paradoxical masseteric bulging after botulinum neurotoxin type A injection","volume":"9","author":"Lee","year":"2016","journal-title":"Toxins (Basel)"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0036-1592089","article-title":"New management in bilateral masseter muscle hypertrophy","volume":"10","author":"Bocchialini","year":"2017","journal-title":"Craniomaxillofac Trauma Reconstr"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0190-9622(96)90016-X","article-title":"Botulinum A exotoxin use in clinical dermatology","volume":"34","author":"Carruthers","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.PRS.0000153236.79775.A0","article-title":"The use of botulinum toxin type A in aesthetic mandibular contouring","volume":"115","author":"Kim","year":"2005","journal-title":"Plast Reconstr Surg"},{"issue":"Suppl 1","key":"R9-20250731","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/DSS.0000000000000162","article-title":"Prolonging the duration of masseter muscle reduction by adjusting the masticatory movements after the treatment of masseter muscle hypertrophy with botulinum toxin type a injection","volume":"41","author":"Wei","year":"2015","journal-title":"Dermatol Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/jocd.12729","article-title":"Italian consensus report on the aesthetic use of onabotulinum toxin A","volume":"17","author":"Bertossi","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/DSS.0000000000001859","article-title":"Botulinum toxin injections for masseter reduction in east Asians","volume":"45","author":"Cheng","year":"2019","journal-title":"Dermatol Surg"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00042728-200505000-00002","article-title":"Effects of botulinum toxin type A on contouring of the lower face","volume":"31","author":"Choe","year":"2005","journal-title":"Dermatol Surg"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/mds.25582","article-title":"Diffusion, spread, and migration of botulinum toxin","volume":"28","author":"Ramirez-Castaneda","year":"2013","journal-title":"Mov Disord"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/DSS.0000000000001439","article-title":"Predictive techniques for neurotoxin outcomes","volume":"44","author":"Brown","year":"2018","journal-title":"Dermatol Surg"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.870090106","article-title":"Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections","volume":"9","author":"Borodic","year":"1994","journal-title":"Mov Disord"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/mus.21343","article-title":"Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg","volume":"40","author":"Carli","year":"2009","journal-title":"Muscle Nerve"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"393e","DOI":"10.1097\/PRS.0000000000003646","article-title":"Facial assessment and injection guide for botulinum toxin and injectable hyaluronic Acid fillers: focus on the lower face","volume":"140","author":"de Maio","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jocd.12473","article-title":"Complications of botulinum toxin injection for masseter hypertrophy: incidence rate from 2036 treatments and summary of causes and preventions","volume":"17","author":"Peng","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jbiomech.2007.11.016","article-title":"Botox produces functional weakness in non-injected muscles adjacent to the target muscle","volume":"41","author":"Yaraskavitch","year":"2008","journal-title":"J Biomech"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/DSS.0000000000000223","article-title":"The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy","volume":"40","author":"Bae","year":"2014","journal-title":"Dermatol Surg"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/dsu.12247","article-title":"Botulinum toxin injection for salivary gland enlargement evaluated using computed tomographic volumetry","volume":"39","author":"Bae","year":"2013","journal-title":"Dermatol Surg"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/DSS.0000000000000510","article-title":"A pilot study on the treatment of posterior cheek enlargement in HIV+ patients with botulinum toxin A","volume":"41","author":"Scali","year":"2015","journal-title":"Dermatol Surg"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/jocd.12667","article-title":"Split face comparison between common concentration vs double dilution of intradermal abobotulinum toxin type A (Dysport) injection for facial lifting in Asians","volume":"17","author":"Sirithanabadeekul","year":"2018","journal-title":"J Cosmet Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:09:34Z","timestamp":1753999774000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000003171","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]}}}